Menu

Spermidine

Also known as: Dietary spermidine, Spermidine-rich wheat germ extract

A polyamine studied in wheat-germ extracts; cellular autophagy research is not a demonstrated memory or human-longevity benefit.

Gouache still life of golden wheat germ flakes and two wheat ears on folded paper
Editorial illustration

Spermidine is a naturally occurring polyamine involved in cellular processes, including autophagy. A 12-month wheat-germ-extract trial did not improve its primary memory outcome versus placebo. That study does not establish dementia prevention or longer human life; the mass of an extract is not its spermidine content.1, 2

  • SmartAge randomized 100 adults aged 60–90 with subjective cognitive decline.1
  • The earlier safety trial used 750 mg/day of extract containing 1.2 mg of spermidine plus other polyamines.2
  • FDA ceased evaluating GRN 889 after identifying deficiencies; it did not issue a no-questions response.3

What is Spermidine?

The body makes polyamines, and food and gut microbial activity also contribute. Human trials here supplied a polyamine-rich wheat-germ extract rather than isolating an effect of pure spermidine. That distinction matters when comparing a powder, a standardized extract and claims drawn from animal experiments.2

Where it comes from

Natural sources

  • Endogenous polyamine production
  • Dietary sources including wheat germ

How it's made

The cited clinical preparations were processed wheat-germ extracts. Other sources and purified compounds need their own specifications and evidence.

What it does in products

  • Ingredient in healthy-aging marketed supplements

Benefits

Memory improvement remains unestablished

insufficient evidence

The larger follow-up did not validate the primary memory benefit. Exploratory findings should not replace that result.1

SmartAge used 0.9 mg/day of spermidine in an extract for one year. Secondary exploratory signals need replication. Some investigators disclosed commercial interests in the extract supplier; the trial did not measure lifespan.

Evidence scope and limitations

Two specified wheat-germ-extract trials in older adults and FDA's GRN 889 response; not an exhaustive review of every polyamine, disease or newer formulation.

  • The primary one-year memory result was negative; exploratory analyses are not confirmation.
  • Small selected samples cannot establish rare-event, pregnancy or lifelong safety.
  • Extract mixtures do not isolate pure spermidine's contribution, and neither trial measured human lifespan.
  • The FDA letter concerns one notified material and proposed food use, not a market-wide verdict.

Evidence last checked: 2026-10-11

Side effects & safety

Incomplete safety information outside selected trial participants (varies)The small three-month study found no important group differences in monitored safety measures. It cannot estimate rare events or clear every population, extract or higher dose.

Safety considerations

  • The cited older-adult studies do not establish pregnancy, breastfeeding or childhood supplement safety.
  • The earlier trial excluded people receiving anticoagulation or platelet-inhibiting therapy; its tolerability result is not a medication-interaction clearance.
  • Not for: The safety study excluded wheat-germ or gluten allergy and a history of malignancy. These exclusions limit generalization; they do not themselves prove that spermidine causes cancer.
  • Not for: Do not treat an animal autophagy result as a reason to replace clinical assessment of memory symptoms.
2, 1

Amounts studied & product use

These figures describe research or common product use, not a personal dose or treatment recommendation.

In supplement studies and products

The trials studied extract-delivered spermidine at 1.2 mg/day for three months and 0.9 mg/day for twelve months. These are research exposures, not recommended personal amounts. Compare declared active content, not just extract milligrams; the preparations also contained other polyamines.

2, 1

Regulatory status

  • For the specific wheat-germ ingredient in GRN 889, FDA stopped its evaluation in March 2020 at the notifier's request after raising manufacturing, specification and exposure deficiencies. This letter is neither a no-questions response nor an efficacy approval. Dietary supplements generally do not receive FDA premarket safety-and-effectiveness approval.
3, 4

Read the response letter, not just the notice number

A manufacturer submitting a GRAS notice and FDA accepting its safety reasoning are different events. GRN 889 documents unresolved questions about that notified material and intended food uses, not a universal ruling on every spermidine product.

Our reading: ask which material was assessed, what the agency actually concluded and what outcome a human trial measured. A notification number cannot repair a null memory result, and an extract trial cannot isolate the contribution of a single polyamine.

3, 1, 2

Frequently asked questions

Are 750 mg of wheat-germ extract and 750 mg of spermidine equivalent?

No. The safety study's 750 mg extract provided 1.2 mg spermidine, alongside spermine and putrescine. Extract weight is not an active-content conversion for another preparation.2

Does autophagy research prove that a supplement extends human life?

No. The cited human studies assessed tolerability and cognitive outcomes, not lifespan extension. Mechanistic plausibility does not supply a clinical longevity endpoint.2, 1

The bottom line

Keep the active-content label, null memory result and actual agency response together; none supports a general anti-aging recommendation.

References

  1. Schwarz C, Benson GS, Horn N, Wurdack K, Grittner U, Schilling R, Märschenz S, Köbe T, Hofer SJ, Magnes C, Stekovic S, Eisenberg T, Sigrist SJ, Schmitz D, Wirth M, Madeo F, Flöel A. Effects of Spermidine Supplementation on Cognition and Biomarkers in Older Adults With Subjective Cognitive Decline: A Randomized Clinical Trial. JAMA Network Open (2022) · randomized trial · PMID 35616942; DOI 10.1001/jamanetworkopen.2022.13875; NCT03094546
  2. Schwarz C, Stekovic S, Wirth M, Benson G, Royer P, Sigrist SJ, Pieber T, Dammbrueck C, Magnes C, Eisenberg T, Pendl T, Bohlken J, Köbe T, Madeo F, Flöel A. Safety and tolerability of spermidine supplementation in mice and older adults with subjective cognitive decline. Aging (2018) · randomized trial · PMID 29315079; DOI 10.18632/aging.101354; NCT02755246; human and mouse results separated
  3. GRAS Notice 889: Agency Response Letter. U.S. Food and Drug Administration (2020) · government guidance · GRN 000889; March 20, 2020; FDA ceased evaluation at notifier's request
  4. Dietary Supplements. U.S. Food and Drug Administration · government guidance · Undated agency resource; accessed October 11, 2026

Revision history

  1. Initial AI-assisted source checks and claim-level citation mapping under the site-authorized publishing workflow. No separate human or independent medical review is claimed.